Home / Stock ratings / Healthcare Stocks / UNH
Stock rating · Hospital & Medical Service Plans
UnitedHealth Group Incorporated (UNH) Stock Rating & Analysis
As of October 7, 2026, MELANY rates UnitedHealth Group Incorporated 70 out of 100 (Highest Conviction). Its highest factor score is catalyst setup at 100, and its lowest is business quality at 41.
MELANY ratingRated 2026-10-07UNH · composite score
About UnitedHealth Group Incorporated
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. A leader in employer-sponsored, self-directed, and government-backed plans, it has large scale in medical insurance, and its Optum franchises extend the company across pharmaceutical benefits, outpatient care, and analytics for affiliates and third parties.
Rating as of 2026-10-07 · this is a dated snapshot; the live rating is in the app (Pro, free for 30 days). The price above updates in real time.
How UNH's rating has moved
- 0Past week, since Sep 30: score held at 70.
- +4Past four weeks, since Sep 9: score rose 4 points to 70.
Weekly points: Sep 9: 66 · Sep 16: 67 · Sep 23: 69 · Sep 30: 70 · Oct 7: 70 (this page).
From MELANY's own dated rating record. A tier change is reported as a move between named tiers; the score carries the direction.
Why UNH scores 70/100
UNH's 8 factor scores run from 41 to 100, and 4 of them sit above its composite of 70. Here is how UNH breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- Forward P/E 16.6x, earnings growth accelerating
- PEG ratio 1.03 (< 1 = undervalued)
- FCF yield 7.2%
Margins, returns on capital, and balance-sheet strength.
Direction and relative strength of the recent share-price trend.
- 50-day MA above 200-day (golden cross zone)
History of beating or missing estimates, and where estimates are heading.
- Beat EPS estimates 3 of last 4 quarters
- Avg EPS beat +10%
- Earnings in 6 days (strong beat history)
What Wall Street price targets and revisions are signalling.
- Analyst targets 28% upside
- Institutional net buying +3.2%
Near-term events that could move the stock.
- Earnings in 6 days
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
How UNH compares
As of October 7, 2026, UnitedHealth Group Incorporated ranks 8th of 20 in Healthcare Stocks, where the average score is 67.
Key risks for UNH
- Earnings report in 6 days, binary outcome can move 10%+ either way
Sector and theme context
UnitedHealth Group Incorporated sits in the Healthcare sector theme, which MELANY currently rates 37/100 for strength. Theme strength feeds UNH's momentum and catalyst factors above.
UNH trade plan (Pro)
MELANY has a full position plan for UnitedHealth Group Incorporated: a smart entry zone, an alert level, position sizing, and quarterly review triggers. It is part of Market Eyes Pro, and the first 30 days are free.
How MELANY rates UNH
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. UnitedHealth Group Incorporated's 70/100 reflects mature factor weighting for its profile. Position framework managed by score-based check-ins, not a fixed holding period.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about UNH
Is UnitedHealth Group Incorporated (UNH) a buy?
As of 2026-10-07, MELANY rated UnitedHealth Group Incorporated Highest Conviction with a composite score of 70/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is UnitedHealth Group Incorporated's MELANY score?
UnitedHealth Group Incorporated (UNH) has a MELANY composite score of 70/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, macro fit.
How is the UNH stock rating calculated?
MELANY scores UNH from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy UnitedHealth Group Incorporated stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates UnitedHealth Group Incorporated (UNH) Highest Conviction with a composite of 70/100 as of 2026-10-07. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the UNH stock price forecast?
MELANY does not publish price targets or forecasts for UNH. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 70/100 across eight factors for UnitedHealth Group Incorporated, and re-scores automatically as new price, earnings, and fundamental data arrive.
Is UNH stock overvalued or undervalued?
MELANY's valuation factor currently reads 65/100 for UnitedHealth Group Incorporated, where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives UNH's read.
What price should I buy UNH at?
Rather than chasing the current price, MELANY computes a smart entry zone for UNH: the price area where risk and reward actually favor a new position, plus an alert level and position sizing. The exact levels are part of Market Eyes Pro, which starts with a 30-day free trial.
What are the risks of buying UNH stock?
The top risks MELANY currently flags for UnitedHealth Group Incorporated: Earnings report in 6 days, binary outcome can move 10%+ either way. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is UnitedHealth Group Incorporated a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 41/100 for UnitedHealth Group Incorporated, and earnings track record, at 81/100. The 70/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will UNH stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 64/100 for UNH right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this UNH rating?
The rating on this page is a snapshot of MELANY's read as of 2026-10-07. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores UNH continuously as new price, earnings, and fundamental data arrive, and the current rating is in the app (Pro, free for 30 days).
How this rating works
Market Eyes Live
Every rating graded in public, UNH included
MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.